Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8801 USD | +10.01% | -2.25% | +18.93% |
23/01 | North American Morning Briefing : Stock Futures Steady as Earnings Season Ramps Up | DJ |
16/01 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar CohBar, Inc.
Upcoming events on CohBar, Inc.
Past events on CohBar, Inc.
06/11/2023 05:30 pm | Extraordinary Shareholders Meeting - Second Call |
04/10/2023 05:30 pm | Extraordinary Shareholders Meeting - M&A Vote |
15/08/2023 01:31 am | Q2 2023 Earnings Release |
03/06/2023 11:45 am | American Society of Clinical Oncology Conference - Abstract #: 9534 |
23/05/2023 06:00 pm | Business Update Call |
16/05/2023 12:22 am | Q1 2023 Earnings Release |
10/03/2023 03:40 am | Q4 2022 Earnings Release |
09/11/2022 03:30 am | Q3 2022 Earnings Call |
08/11/2022 | Q3 2022 Earnings Release After hours |
12/09/2022 04:30 pm | H.C. Wainwright Global Investment Conference |
16/08/2022 02:30 am | Interim 2022 Earnings Call |
16/08/2022 01:32 am | Interim 2022 Earnings Release |
30/06/2022 11:00 pm | Longevity Therapeutics Summit - Panel |
15/06/2022 11:00 pm | Annual General Meeting |
15/06/2022 | BIO International Convention |
24/05/2022 04:30 pm | H.C. Wainwright Global Life Sciences Investment Conference |
17/05/2022 02:30 am | Q1 2022 Earnings Call |
17/05/2022 01:31 am | Q1 2022 Earnings Release |
30/03/2022 02:30 am | FY 2021 Earnings Call |
30/03/2022 01:31 am | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -13,2 -12,0 -10.09% | -15,1 -17,0 10.98% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -15,5 -17,0 9.21% |
Net income Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -15,5 -17,0 9.21% |
EPS USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -6,90 -7,50 8% |
Announcement Date | 12/03/20 | 30/03/21 | 29/03/22 |
Quarterly results
Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
EBIT Million USD | Released Forecast Spread | -5,20 -3,92 -32.8% | -3,41 -4,85 29.73% | -2,48 -4,35 43% | -3,25 -3,91 16.88% | -2,74 -3,79 27.61% | -2,47 -3,06 19.23% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,22 -4,01 -30.14% | -3,42 -5,28 35.15% | -2,79 -4,36 35.89% | -3,26 -3,91 16.67% | -2,72 -3,79 28.14% | |
Net income Million USD | Released Forecast Spread | -5,22 -4,17 -25.3% | -3,42 -4,90 30.11% | -2,79 -4,36 35.89% | -3,26 -3,91 16.67% | -2,72 -3,79 28.14% | |
EPS USD | Released Forecast Spread | -2,40 -2,00 -20% | -1,50 -2,25 33.33% | -0,90 -1,50 40% | -1,20 -1,35 11.11% | -0,90 -1,20 25% | |
Announcement Date | 10/08/21 | 15/11/21 | 29/03/22 | 16/05/22 | 15/08/22 | 08/11/22 |
Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for CohBar, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CWBR Stock
- Calendar CohBar, Inc.